$Comparison of clinical features and conventional echocardiographic characteristics of patients with heart failure with mid-range ejection fraction with and without interatrial block$
Código QR

Código QR

Comparison of clinical features and conventional echocardiographic characteristics of patients with heart failure with mid-range ejection fraction with and without interatrial block

Guardado en:

Detalles Bibliográficos
Autores principales:	Mustafa Doğduş, İlhan Koyuncu
Formato:	article
Lenguaje:	EN TR
Publicado:	KARE Publishing 2021
Materias:	Medicine R Internal medicine RC31-1245 Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/58aa5ba0bc9e45588ea223f29ff59830
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Comparison of clinical features and conventional echocardiographic characteristics of patients with heart failure with mid-range ejection fraction with and without interatrial block
por: Ali Çoner
Publicado: (2021)

Heart Failure With Mid-range or Recovered Ejection Fraction: Differential Determinants of Transition
por: Davide Margonato, et al.
Publicado: (2020)

Interatrial shunt devices for heart failure with normal ejection fraction: a technology update
por: Cuthbert JJ, et al.
Publicado: (2017)

Pheochromocytoma: An overlooked reversible cause of heart failure with reduced ejection fraction
por: Ali Çoner, et al.
Publicado: (2021)

Angiotensin receptor neprilysin inhibitor for patients with heart failure and reduced ejection fraction: Real-world experience from Turkey (ARNi-TR)
por: Berkay Ekici, et al.
Publicado: (2021)

Deep Learning Predicts Heart Failure With Preserved, Mid-Range, and Reduced Left Ventricular Ejection Fraction From Patient Clinical Profiles
por: Mohanad Alkhodari, et al.
Publicado: (2021)

The profile of selected single nucleotide polymorphisms in patients with hypertension and heart failure with preserved and mid-range ejection fraction
por: Agata Bielecka-Dabrowa, et al.
Publicado: (2017)

Wild type transthyretin cardiac amiloidozis as a rare and overlooked underlying etiology in a patient with heart failure with preserved ejection fraction and left ventricular hypertrophy
por: Selda Murat, et al.
Publicado: (2021)

Extension of a mitral-aorta intervalvular fibrosa pseudoaneurysm into the interatrial septum resulting in the honeycomb appearance in a patient with Takayasu’s arteritis
por: Ali Hosseinsabet, et al.
Publicado: (2021)

Prognostic value of high-sensitivity cardiac troponin I in heart failure patients with mid-range and reduced ejection fraction.
por: Petr Lokaj, et al.
Publicado: (2021)

Classification of heart failure: A farewell to ejection fraction?
por: Thomas F. Lüscher
Publicado: (2021)

Interatrial Shunting for Treating Acute and Chronic Left Heart Failure
por: Leonardo Guimaraes, et al.
Publicado: (2020)

Suppression of Tumourigenicity 2 in Heart Failure With Preserved Ejection Fraction
por: Veronika Zach, et al.
Publicado: (2020)

Resumption of interatrial conduction after atrial premature beat in baseline interatrial aberrancy
por: Voravut Rungpradubvong
Publicado: (2021)

Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fraction
por: Maria Vincenza Polito, et al.
Publicado: (2020)

Echocardiographic assessment of inter and intraventricular dyssynchrony in heart failure patients with reduced ejection fraction and normal QRS duration using tissue doppler imaging, 2D echocardiography and M-mode
por: Varun Mitra Vallabhapurapu, et al.
Publicado: (2021)

Role of nutritional supplementation in heart failure with reduced ejection fraction
por: Yash Paul Sharma, et al.
Publicado: (2021)

Determinants of gait speed in patients with heart failure with reduced ejection fraction
por: Aylin Tanrıverdi, et al.
Publicado: (2021)

Echocardiographic Findings and Genotypes in Autosomal Dominant Polycystic Kidney Disease
por: Ryohei Miyamoto, et al.
Publicado: (2021)

The importance of bedside echocardiographic assessment in emergency admissions with probable acute coronary syndromes: A case of an unruptured giant ascending aorta aneurysm
por: Hüseyin Ede, et al.
Publicado: (2021)

Effects of Exercise Training on Cardiac Function in Heart Failure with Preserved Ejection Fraction
por: Hidekatsu Fukuta
Publicado: (2020)

Transcriptomic Research in Heart Failure with Preserved Ejection Fraction: Current State and Future Perspectives
por: Sebastian Rosch, et al.
Publicado: (2020)

Cardiac Transthyretin-derived Amyloidosis: An Emerging Target in Heart Failure with Preserved Ejection Fraction?
por: Sebastiaan HC Klaassen, et al.
Publicado: (2020)

A profile of heart failure with preserved ejection fraction in a teaching institute
por: Gaurav Aggarwal, et al.
Publicado: (2021)

Optimizing Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction During Hospitalization
por: Neal M Dixit, et al.
Publicado: (2021)

Rationale for and Practical Use of Sacubitril/Valsartan in the Patient’s Journey with Heart Failure and Reduced Ejection Fraction
por: Mauro Gori, et al.
Publicado: (2021)

Prescription of Sacubitril/Valsartan in Patients with Heart Failure and Reduced Ejection Fraction Attending an Outpatient Heart Failure Clinic
por: M Rizzo, et al.
Publicado: (2020)

Body Mass Index: An Effective Predictor of Ejection Fraction Improvement in Heart Failure
por: Li-fang Ye, et al.
Publicado: (2021)

Time in therapeutic range values of patients using warfarin and factors that influence time in therapeutic range
por: Lale Dinç Asarcıklı, et al.
Publicado: (2021)

Hyperkalemia and Renin–Angiotensin–Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction
por: Giuseppe MC Rosano, et al.
Publicado: (2019)

Use of Renin–Angiotensin–Aldosterone System Inhibitors in Older Patients with Heart Failure and Reduced Ejection Fraction
por: Davide Stolfo, et al.
Publicado: (2019)

Mild aortic valve disease and the diastolic pressure–volume relationship in heart failure with preserved ejection fraction
por: Mackram F Eleid, et al.
Publicado: (2021)

Readmissions, Death and Its Associated Predictors in Heart Failure With Preserved Versus Reduced Ejection Fraction
por: Wan Ting Tay, et al.
Publicado: (2021)

Evaluation of potential underuse of cardiac resynchronization therapy for heart failure with reduced ejection fraction
por: Makoto Takano, et al.
Publicado: (2021)

Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction
por: Nancy Luo, MD, MHS, et al.
Publicado: (2021)

Machine learning based diagnosis of heart failure with preserved ejection fraction among South Asian patients
por: Ananya Achanta, et al.
Publicado: (2021)

Distal transradial versus conventional transradial access in acute coronary syndrome
por: Kenan Erdem, et al.
Publicado: (2021)

Tolerability Profile and Discontinuation Causes of Sacubitril/Valsartan Treatment in ‘Real-life’ Patients with Heart Failure and Reduced Ejection Fraction
por: M Rizzo, et al.
Publicado: (2020)

Features of heart failure with preserved ejection fraction (HFpEF) in diabetic patients with resistant hypertension
por: M. A. Manukyan, et al.
Publicado: (2021)

Tissue doppler, strain imaging and conventional 2-dimensional echocardiographic assessments in multi-transfused thalassemic children with iron overload
por: Murtaza DR. Kamal, et al.
Publicado: (2021)